查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855462

動物鎮靜劑市場：依產品類型、動物類型、應用、通路和最終用戶分類－2025-2032年全球預測

Animal Sedative Market by Product Type, Animal Type, Application, Distribution Channel, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物鎮靜劑市場規模將達到 2.5856 億美元，複合年成長率為 13.94%。

關鍵市場統計數據
基準年 2024 9102萬美元
預計年份：2025年 1.0374億美元
預測年份 2032 2.5856億美元
複合年成長率 (%) 13.94%

概述了正在重塑獸醫鎮靜劑選擇和使用方式的不斷變化的臨床需求、監管考慮因素和製劑進步。

隨著獸醫學的進步與不斷變化的臨床需求和監管審查相交織，獸用鎮靜治療領域正在迅速發展。臨床醫生尋求能夠兼顧各種動物種類和手術操作的療效和安全性的藥物，而飼主和相關人員則要求藥物能夠產生可預測的行為和生理反應，以支持診斷、外科手術和日常護理。同時，製劑和給藥途徑的創新正在拓展臨床和現場的實際應用選擇，凸顯了基於實證醫學選擇和管理鎮靜藥物的重要性。

在此背景下，業界必須兼顧有效鎮靜通訊協定的需求、動物福利考量、食用動物體內藥物殘留問題以及獸醫服務提供者的營運需求。這一趨勢正推動產品採用以數據為中心的策略，產品性能的比較、物流處理以及與多種藥物鎮痛方案的兼容性等因素日益體現在採購和臨床指南中。因此，各市場的製造商、經銷商和臨床負責人正在調整其策略，以符合從業人員的偏好和監管要求。

現代化臨床實踐、日益嚴格的監管以及數位化和供應鏈創新如何重新定義獸醫鎮靜劑生產商和診所的成功因素

獸用鎮靜劑市場格局正再形成，這些變革遠不止於產品創新。臨床實踐正朝著多模式治療方向發展，將鎮靜劑與鎮痛藥和多模態相結合，在保持療效的同時最大限度地減少藥物劑量，並提高安全性和恢復率。同時，監管機構對管制藥品和牲畜殘留限量的日益關注，促使生產商最佳化標籤、停藥指導和供應鏈可追溯性，以維持市場准入和臨床醫生的信任。

技術和營運方面的變革也顯而易見。用於劑量計算的數位化工具、用於遠距行為評估的遠距會診平台以及電子健康記錄，使得鎮靜通訊協定的實施更加規範一致，並有助於術後監測。同時，透過電子商務通路、整合經銷夥伴關係以及溫控物流實現的供應鏈現代化，正在改變產品的可及性，並加快臨床應用的速度。總而言之，這些發展正在建構一個生態系統，在這個系統中，臨床療效、法規遵循和物流可靠性對於長期成功都同等重要。

評估關稅波動和貿易政策發展如何影響動物鎮靜劑相關人員的供應鏈選擇、採購行為和長期策略定位。

貿易政策調整和關稅變動對獸藥採購動態有顯著影響。關稅會改變到岸成本，促進生產在地化，並影響品牌藥和非專利藥的選擇，尤其對於大宗生產和對溫度敏感的鎮靜劑更是如此。進口關稅上漲可能導致經銷商和診所優先選擇國產製劑或簽訂長期合約以規避價格波動風險，這也會影響生產商的市場准入和投資策略。

此外，關稅帶來的成本壓力往往促使供應鏈多元化。企業可能會探索替代採購管道、轉移製造地或重組分銷模式，以維持利潤率並確保供應的連續性。下游方面，動物保健服務提供者會調整庫存政策和臨床通訊協定，以反映產品供應和成本的變化。諸如此類的應對措施凸顯了積極監測貿易政策和進行情境規劃的重要性，這有助於相關人員減輕干擾、維持臨床標準，並確保醫療機構能夠持續獲得必要的鎮靜劑。

以細分市場主導的洞察，揭示產品類型、動物類型、應用領域和分銷管道如何影響臨床和商業策略以及最終用戶的期望。

對細分市場的深入理解有助於更透徹地洞察產品性能和市場機會。依產品類型分類，我們將重點放在吸入、注射和口服給藥方式的不同操作特性和臨床醫生偏好，輸注起效時間、持續時間、給藥便利性和監測負擔等因素會影響不同環境下的臨床應用。根據動物種類，伴侶動物、馬科動物和家畜的治療需求差異顯著，導致製劑、劑量指導以及殘留和清除問題等方面的優先考慮因素不同，這些都會影響臨床方案設計和監管標籤。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在風險較高的馬匹手術中，新型長效鎮靜劑製劑的應用日益增加。
  • 加大對物種特異性鎮靜劑研究的投入，以最大程度地減少不良反應
  • 將數位化監測整合到小動物鎮靜方案中以最佳化劑量
  • 監管政策的變化推動了獸醫領域對植物來源鎮靜劑的需求。
  • 用於伴侶動物微創鎮靜的擴展型可注射經皮吸收貼片
  • 畜牧管理中對多重止痛鎮靜療法的偏好日益增加

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依產品類型分類的動物鎮靜劑市場

  • 吸入劑
  • 注射
  • 口服

第9章 依動物類型分類的動物鎮靜劑市場

  • 伴侶動物
  • 馬
  • 家畜

第10章 動物鎮靜劑市場依應用領域分類

  • 行為管理
  • 診斷程序
  • 外科手術

第11章 動物鎮靜劑市場及通路

  • 網路藥房
    • 製造商網站
    • 第三方網站
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房
  • 動物診所
  • 獸醫診所

第12章：依最終用戶分類的動物鎮靜劑市場

  • 研究所
  • 動物診所
  • 動物用藥品經銷商
  • 獸醫診所

第13章：各地區動物鎮靜劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依類別分類的動物鎮靜劑市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國動物鎮靜劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim Animal Health GmbH
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Virbac SA
    • Dechra Pharmaceuticals Plc
    • Norbrook Laboratories Ltd
    • Heska Corporation
Product Code: MRR-8652FEF459B1

The Animal Sedative Market is projected to grow by USD 258.56 million at a CAGR of 13.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 91.02 million
Estimated Year [2025] USD 103.74 million
Forecast Year [2032] USD 258.56 million
CAGR (%) 13.94%

An overview of changing clinical demands regulatory considerations and formulation advances that are reshaping selection and use of sedative agents across veterinary care settings

The therapeutic and procedural landscape for animal sedatives has evolved rapidly as advances in veterinary practice intersect with shifting clinical expectations and regulatory scrutiny. Clinicians increasingly demand agents that balance efficacy with safety across diverse species and procedures, while owners and institutional stakeholders seek predictable behavioral and physiological responses to support diagnostic, surgical, and routine care. Meanwhile, innovation in formulation and delivery routes has expanded practical options in clinics and field settings, amplifying the importance of evidence-driven selection and stewardship of sedative agents.

Against this backdrop, the industry must reconcile the need for effective sedation protocols with heightened emphasis on animal welfare, drug residue considerations in food-producing species, and the operational imperatives of veterinary service providers. These dynamics are driving a more data-centric approach to product adoption, where comparative performance, handling logistics, and compatibility with multimodal analgesia inform procurement and clinical guidelines. As a result, manufacturers, distributors, and clinical leaders are recalibrating strategies to align with both practitioner preferences and regulatory expectations across markets.

How clinical practice modernization regulatory tightening and digital and supply chain innovations are jointly redefining manufacturer and clinic success factors in veterinary sedation

The market environment for animal sedatives is being reshaped by several transformative shifts that extend beyond simple product innovation. Clinical practice has moved toward multimodal approaches that integrate sedatives with analgesics and anxiolytics to minimize drug doses while preserving efficacy, thereby improving safety margins and recovery profiles. Concurrently, heightened regulatory attention on controlled substances and residue limits in livestock has pressured manufacturers to optimize labeling, withdrawal guidance, and supply chain traceability to maintain market access and clinician confidence.

Technological and operational shifts are also evident. Digital tools for dosing calculations, teleconsultation platforms for remote behavioral assessment, and electronic medical records are enabling more consistent application of sedation protocols and facilitating post-procedure monitoring. In parallel, supply chain modernization-driven by e-commerce channels, integrated distribution partnerships, and temperature-controlled logistics-has altered product availability and the speed of clinical adoption. Taken together, these developments are creating an ecosystem where clinical efficacy, regulatory compliance, and logistical reliability are equally critical for long-term success.

Evaluating how tariff shifts and trade policy developments are influencing supply chain choices procurement behavior and long-term strategic positioning for veterinary sedative stakeholders

Trade policy adjustments and tariff movements have a measurable influence on the procurement dynamics of pharmaceutical supplies used in veterinary practice. Tariffs can change landed costs, incentivize localization of production, and affect the choice between branded and generic products, particularly for high-volume or temperature-sensitive sedatives. When import duties rise, distributors and clinics may prioritize domestically produced formulations or negotiate longer-term contracts to insulate against price volatility, which in turn affects manufacturers' market entry and investment strategies.

In addition, tariff-driven cost pressures often prompt supply chain diversification. Companies may seek alternative sourcing routes, shift manufacturing footprints, or restructure distribution models to maintain margin integrity and ensure continuity of supply. Downstream, veterinary service providers adjust inventory policies and clinical protocols to reflect changes in product availability and cost. These responses emphasize the importance of proactive trade policy monitoring and scenario planning so that stakeholders can mitigate disruption, preserve clinical standards, and sustain access to essential sedative agents across care settings.

Segment-driven insights that clarify how distinct product types animal classes applications and distribution pathways shape clinical choices commercial strategies and end-user expectations

A granular understanding of segmentation deepens insight into product performance and commercial opportunity. Based on Product Type, attention centers on the distinct operational characteristics and clinician preferences for Inhalant, Injectable, and Oral modalities, where considerations such as onset time, duration, ease of administration, and monitoring burden shape clinical adoption across settings. Based on Animal Type, therapeutic demands vary substantially among Companion Animals, Equine, and Livestock, creating divergent priorities in formulation, dosing guidance, and residue or clearance concerns that influence both clinical protocol design and regulatory labeling.

Based on Application, use-case specificity is paramount; Behavioral Management, Diagnostic Procedures, and Surgical Procedures each impose unique efficacy and safety requirements, leading to differentiated product positioning and educational needs. Based on Distribution Channel, the landscape includes Online Pharmacies, Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals, with Online Pharmacies further delineated into Manufacturer Website and Third-Party Website, and Retail Pharmacies further divided into Chain Pharmacies and Independent Pharmacies, all of which influence purchasing behavior, margin structures, and point-of-care accessibility. Finally, Based on End User, the roles of Research Institutes, Veterinary Clinics, Veterinary Drug Distributors, and Veterinary Hospitals determine demand profiles, procurement cycles, and expectations for technical support and post-sale services.

A cross-regional perspective on how regulatory regimes clinical practice maturity and cultural attitudes across the Americas Europe Middle East & Africa and Asia-Pacific influence product strategies

Regional dynamics continue to shape clinical practice, regulatory frameworks, and commercial models for sedative agents. In the Americas, a mature veterinary infrastructure and strong private clinic networks drive demand for advanced formulations and practice-level services, while regulatory oversight and stakeholder expectations emphasize pharmacovigilance and controlled-substance management. In Europe, Middle East & Africa, heterogeneity is pronounced: regulatory stringency and welfare standards in parts of Europe contrast with developing-market needs across some Middle Eastern and African jurisdictions, which affects access models, pricing strategies, and the pace of clinical guideline harmonization.

In the Asia-Pacific region, rapid expansion of veterinary services, rising pet ownership, and growing investments in livestock production create opportunities for broader adoption of diverse sedative modalities, yet pricing sensitivity and fragmented distribution can limit uptake of higher-cost innovations. Across all regions, local regulatory landscapes, cultural attitudes toward animal care, and the maturity of veterinary education systems play decisive roles in the diffusion of new products and protocols. Consequently, region-specific go-to-market strategies, regulatory engagement plans, and clinician education initiatives are crucial for any organization seeking sustainable presence across these geographies.

Key competitive and partnership trends among manufacturers distributors and clinical stakeholders that are determining product differentiation and go-to-market effectiveness in the sedatives arena

Competitive dynamics in the animal sedative space reflect a mixture of established veterinary pharmaceutical manufacturers and specialized innovators. Industry leaders emphasize robust clinical trial programs, comprehensive safety data, and strong regulatory dossiers to support adoption among veterinarians and institutional purchasers. Concurrently, a cohort of agile players is advancing niche formulations, novel delivery mechanisms, and companion diagnostic tools that aim to differentiate on ease-of-use, safety, and species-specific performance.

Strategic partnerships between manufacturers and distribution networks, as well as alliances with veterinary professional associations and academic centers, are increasingly common to accelerate clinical validation and guideline incorporation. Mergers and selective licensing deals continue to shape the landscape, enabling companies to broaden portfolios and access new geographic channels. For stakeholders, the imperative is to combine scientific rigor with pragmatic commercialization tactics, ensuring that product claims are substantiated, post-market surveillance is robust, and clinician support programs address real-world administration and monitoring challenges.

Actionable strategic priorities for manufacturers distributors and clinical leaders focused on evidence building supply chain resilience regulatory engagement and channel-optimized commercialization

Leaders in the sector should prioritize a balanced agenda that integrates clinical evidence generation, regulatory foresight, and supply chain resilience. Investing in rigorous comparative studies and real-world evidence will strengthen product value propositions and facilitate guideline inclusion. At the same time, proactive regulatory engagement focused on labeling, residue management for food-producing animals, and controlled-substance compliance will reduce market access risk and enhance stakeholder trust. Operationally, establishing diversified manufacturing footprints and contingency sourcing arrangements can mitigate the impact of trade policy changes and tariff volatility.

Commercially, firms should tailor distribution strategies to the channel dynamics identified earlier, ensuring that online and retail pathways complement clinic- and hospital-based access, while providing education and technical support to end users. Collaborative initiatives with veterinary training programs and professional societies can accelerate adoption and standardize protocols. Finally, embedding digital tools for dosing decision support and post-procedure monitoring will improve clinical outcomes and create differentiation, making it easier to demonstrate the practical benefits of specific sedative solutions to both clinicians and institutional purchasers.

A clear explanation of the mixed-methods research approach combining practitioner interviews clinical literature regulatory review and cross-validation to ensure robust and reproducible insights

This analysis synthesizes a mixed-methods approach integrating primary qualitative inputs and rigorous secondary research to ensure comprehensive coverage and verifiable conclusions. Primary research involved structured interviews with practicing veterinarians, clinical pharmacologists, distribution executives, and procurement specialists to capture first-hand perspectives on product performance, procurement constraints, and evolving clinical protocols. These insights were triangulated with secondary sources including peer-reviewed literature, regulatory guidance documents, and product labeling to validate clinical assertions and safety considerations.

Data integrity was reinforced through cross-validation across multiple stakeholder groups and regions, with attention to methodological transparency and reproducibility. Where possible, comparative analyses focused on publicly available clinical data, pharmacokinetic profiles, and regulatory records to support claims about relative advantages and implementation considerations. Limitations include variability in reporting standards across jurisdictions and the evolving nature of regulatory guidance, which the methodology addresses through periodic updates and sensitivity checks to maintain relevance and accuracy over time.

A synthesis of strategic imperatives and practical takeaways that emphasize evidence alignment regulatory preparedness and distribution agility as drivers of durable success

The collective findings underscore a consistent theme: success in the animal sedative domain depends on aligning clinical performance with regulatory compliance and pragmatic distribution practices. Stakeholders must navigate species-specific requirements, application-driven performance expectations, and geographically diverse regulatory regimes while maintaining operational agility that addresses supply chain and tariff-related risks. Integrating evidence generation with clinician education and channel-specific commercialization will be central to driving adoption and ensuring long-term clinical and commercial viability.

Looking ahead, organizations that invest in robust safety and efficacy data, cultivate strategic partnerships across distribution and clinical education networks, and implement flexible supply strategies will be best positioned to respond to changing regulatory and market conditions. In essence, a coordinated approach that marries scientific credibility with practical execution will deliver the greatest benefit to animal health professionals and the animals they serve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of novel long-acting sedative formulations for high-risk equine surgeries
  • 5.2. Rising investment in species-specific sedative research to minimize adverse reactions
  • 5.3. Integration of digital monitoring for dosage optimization in small animal sedation protocols
  • 5.4. Regulatory shifts driving demand for plant-derived sedatives in veterinary practice
  • 5.5. Expansion of injectable transdermal patches for minimally invasive sedation in companion animals
  • 5.6. Growing preference for multimodal analgesia and sedation combinations in livestock management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Sedative Market, by Product Type

  • 8.1. Inhalant
  • 8.2. Injectable
  • 8.3. Oral

9. Animal Sedative Market, by Animal Type

  • 9.1. Companion Animals
  • 9.2. Equine
  • 9.3. Livestock

10. Animal Sedative Market, by Application

  • 10.1. Behavioral Management
  • 10.2. Diagnostic Procedures
  • 10.3. Surgical Procedures

11. Animal Sedative Market, by Distribution Channel

  • 11.1. Online Pharmacies
    • 11.1.1. Manufacturer Website
    • 11.1.2. Third-Party Website
  • 11.2. Retail Pharmacies
    • 11.2.1. Chain Pharmacies
    • 11.2.2. Independent Pharmacies
  • 11.3. Veterinary Clinics
  • 11.4. Veterinary Hospitals

12. Animal Sedative Market, by End User

  • 12.1. Research Institutes
  • 12.2. Veterinary Clinics
  • 12.3. Veterinary Drug Distributors
  • 12.4. Veterinary Hospitals

13. Animal Sedative Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Sedative Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Sedative Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Merck & Co., Inc.
    • 16.3.3. Elanco Animal Health Incorporated
    • 16.3.4. Boehringer Ingelheim Animal Health GmbH
    • 16.3.5. Ceva Sante Animale S.A.
    • 16.3.6. Vetoquinol S.A.
    • 16.3.7. Virbac S.A.
    • 16.3.8. Dechra Pharmaceuticals Plc
    • 16.3.9. Norbrook Laboratories Ltd
    • 16.3.10. Heska Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL SEDATIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANIMAL SEDATIVE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANIMAL SEDATIVE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL SEDATIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL SEDATIVE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL SEDATIVE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. GCC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GCC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GCC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. GCC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. GCC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. GCC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. GCC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. GCC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. GCC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GCC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. GCC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 304. GCC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 305. GCC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 306. GCC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 307. GCC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. GCC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. BRICS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 336. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 337. BRICS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 338. BRICS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 339. BRICS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. BRICS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. G7 ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILL